Bicara Therapeutics Inc (BCAX)

May 05, 2026

Bicara Therapeutics Chief Medical Officer Sells 5,500 Shares for $126,000 - AOL.com

May 05, 2026

May 05, 2026

Claire Mazumdar: A silent force behind a $1.6 billion firm may write Biocon's future scripts - The Economic Times

May 05, 2026

May 04, 2026

Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET - The Manila Times

May 04, 2026

May 04, 2026

Bicara Therapeutics Inc. schedules May 11 conference for first quarter 2026 financial results - Traders Union

May 04, 2026

May 04, 2026

Bicara posts Q1 results May 11, with business update before market - Stock Titan

May 04, 2026

Apr 28, 2026

Insider Selling: Bicara Therapeutics (NASDAQ:BCAX) Insider Sells 5,500 Shares of Stock - MarketBeat

Apr 28, 2026

Apr 28, 2026

Bicara Therapeutics CMO David Raben sells $125,830 in shares By Investing.com - Investing.com Canada

Apr 28, 2026

Apr 28, 2026

Bicara Therapeutics CMO David Raben sells $125,830 in shares - Investing.com

Apr 28, 2026

Apr 28, 2026

Bicara Therapeutics (BCAX) CMO sells 5,500 shares after option exercise - Stock Titan

Apr 28, 2026

Apr 28, 2026

BCAX SEC FilingsBicara Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 28, 2026

Apr 27, 2026

5,500-share sale planned by BCAX (BCAX) via Form 144 on 04/27/2026 - Stock Titan

Apr 27, 2026

Apr 27, 2026

Wall Street Analysts Believe Bicara Therapeutics Inc. (BCAX) Could Rally 54.85%: Here's is How to Trade - MSN

Apr 27, 2026

Apr 27, 2026

Bicara Therapeutics (BCAX) details 2026 vote on directors and KPMG - Stock Titan

Apr 27, 2026

Apr 25, 2026

Certain Stock Option of Bicara Therapeutics Inc. are subject to a Lock-Up Agreement Ending on 26-APR-2026. - marketscreener.com

Apr 25, 2026

Apr 23, 2026

BCAX (Bicara Therapeutics Inc.) posts narrow Q4 2025 EPS beat, shares tick higher following its quarterly earnings announcement.Social Momentum Signals - UBND thành phố Hải Phòng

Apr 23, 2026

Apr 22, 2026

Bicara Therapeutics CFO Hyep sells $211k in stock By Investing.com - Investing.com South Africa

Apr 22, 2026

Apr 22, 2026

Bicara Therapeutics CFO Hyep sells $211k in stock - Investing.com

Apr 22, 2026

Apr 22, 2026

Insider Selling: Bicara Therapeutics (NASDAQ:BCAX) CFO Sells 9,200 Shares of Stock - MarketBeat

Apr 22, 2026

Apr 22, 2026

[Form 4] Bicara Therapeutics Inc. Insider Trading Activity - Stock Titan

Apr 22, 2026

Apr 21, 2026

BCAX (BCAX) Form 144 shows option exercise and multiple insider sales - Stock Titan

Apr 21, 2026

Apr 20, 2026

Bicara Therapeutics (NASDAQ:BCAX) CEO Claire Mazumdar Sells 15,000 Shares - MarketBeat

Apr 20, 2026

Apr 20, 2026

Bicara Therapeutics CEO Mazumdar sells $354k in stock By Investing.com - Investing.com Canada

Apr 20, 2026

Apr 20, 2026

Bicara Therapeutics CEO Mazumdar sells $354k in stock - Investing.com

Apr 20, 2026

Apr 20, 2026

Bicara Therapeutics (BCAX) CEO sells 15K shares, exercises 37,760 options - Stock Titan

Apr 20, 2026

Apr 20, 2026

BCAX (BCAX) notice: 15,000 shares to be sold after option exercise - Stock Titan

Apr 20, 2026

Apr 18, 2026

Bicara Therapeutics stock hits 52-week high at 24.14 USD By Investing.com - Investing.com India

Apr 18, 2026

Apr 18, 2026

Cohlhepp Ryan, president and COO of Bicara, sells $287k in BCAX stock - Investing.com India

Apr 18, 2026

Apr 17, 2026

Bicara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛

Apr 17, 2026

Apr 17, 2026

Insider Selling: Bicara Therapeutics (NASDAQ:BCAX) COO Sells 12,500 Shares of Stock - MarketBeat

Apr 17, 2026

Apr 17, 2026

Bicara Therapeutics (BCAX) president exercises options and sells 12,500 shares - Stock Titan

Apr 17, 2026

Apr 17, 2026

Bicara Therapeutics stock hits 52-week high at 24.14 USD - Investing.com

Apr 17, 2026

Apr 17, 2026

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Assessing a 27% Upside Potential for this Biotech Innovator - DirectorsTalk Interviews

Apr 17, 2026

Apr 15, 2026

Insider sales and option exercises reported for BCAX (NASDAQ: BCAX) - Stock Titan

Apr 15, 2026

Apr 15, 2026

Bicara Therapeutics Inc. (NASDAQ:BCAX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Apr 15, 2026

Apr 13, 2026

Bicara Therapeutics (NASDAQ:BCAX) Reaches New 52-Week HighTime to Buy? - MarketBeat

Apr 13, 2026

Apr 13, 2026

History Review: Is Bicara Therapeutics Incs growth already priced inOptions Play & Technical Buy Zone Confirmation - baoquankhu1.vn

Apr 13, 2026

Apr 13, 2026

CEO Moves: How liquid is Bicara Therapeutics Inc stockWeekly Risk Report & Free Reliable Trade Execution Plans - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

BCAX PE Ratio & Valuation, Is BCAX Overvalued - Intellectia AI

Apr 10, 2026

Apr 10, 2026

Published on: 2026-04-10 20:40:14 - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Trading Recap: How is Bicara Therapeutics Inc managing supply chain issues2026 Retail & Free Technical Pattern Based Buy Signals - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Bicara Therapeutics stock hits 52-week high at 21.99 USD By Investing.com - Investing.com Australia

Apr 10, 2026